Skip to main content
. Author manuscript; available in PMC: 2017 Jan 11.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2016 Sep 3;96(5):1054–1059. doi: 10.1016/j.ijrobp.2016.08.042

Table 2.

Worst Reported Treatment-Related Adverse Event–Grade 3 in 4/52 Patients (7.7%)

G3 Adverse Event* n (%) Months Since Start of Treatment (Mean)
Radiation Dermatitis 1 (2%) 1.2
Myositis 1 (2%) 5.3
Skin Fibrosis 2 (4%) 45.4
Telangiectasia 2 (4%) 61.2
Fibrosis - Cosmesis 1 (2%) 85.3
*

3 of 4 patients reported >1 adverse event